DEFINITIVE PROXY STATEMENT

Company

Lineage Cell Therapeutics, Inc.

Filed

April 16, 1998

Period of Report

June 30, 1997

Accession Number

0000876343-98-000008

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →